About this trial
This study aims to evaluate a catheter-free method for delivering medications directly into the bladder, known as intravesical instillation, which is commonly used to treat conditions such as interstitial cystitis/bladder pain syndrome (IC/BPS), recurrent urinary tract infections, bladder cancer, and post-chemotherapy or post-radiation cystitis.
The study investigates whether this method, which eliminates the need for catheterization, reduces discomfort and complications while maintaining treatment effectiveness. By collecting data on patient experiences and outcomes, the study seeks to determine if this approach provides a safer and more comfortable alternative to traditional catheter-based treatments.
Eligibility criteria
Qualifiers
Male and female patients aged between 18 and 80 years.
Interstitial cystitis/bladder pain syndrome (IC/BPS).
Recurrent urinary tract infections (UTIs).
Non-muscle invasive bladder cancer.
Disqualifiers
Urinary tract infection within the past month or currently active infection.
Diagnosed bleeding disorders or recurrent macroscopic hematuria.
Post-void residual urine volume greater than 100 ml.
Mental condition that prevents reliable cooperation.
Trial design
Treatments tested in this trial
- Catheter-Free Intravesical Instillation with a special syringe adapter